de novo
-
Recon
FDA Authorizes Marketing of New Implant to Repair a Torn ACL
SILVER SPRING, Md., Dec. 16, 2020 /PRNewswire/ — Today, the U.S. Food and Drug Administration granted marketing authorization—under the De Novo premarket review…
Read More » -
Hospitals
SANUWAVE Health Submits de novo Petition for FDA Review and Classification of the dermaPACE System to Treat Diabetic Foot Ulcers
ALPHARETTA, Ga., Aug. 11, 2016 (GLOBE NEWSWIRE) — SANUWAVE Health, Inc. (OTCBB:SNWV) today announced that it has submitted to the…
Read More »